Abstract:BACKGROUND: Clock genes drive about 5-15% of genome-wide mRNA expression, and disruption of the circadian clock may deregulate the cell's normal biological functions. Cryptochrome 1 is a key regulator of the circadian feedback loop and plays an important role in organisms. The present study was conducted to investigate the expression of Cry1 and its prognostic significance in colorectal cancer (CRC). In addition, the function of Cry1 in human CRC was investigated in cell culture models.METHODS: Real-time quantitative PCR, Western blot analysis and immunohistochemistry were used to explore Cry1 expression in CRC cell lines and primary CRC clinical specimens. MTT and colony formation assays were used to determine effects on cellular proliferation ability. The animal model was used to explore the Cry1 impact on the tumor cellular proliferation ability in vivo. Transwell assays were performed to detect the migration ability of the cell lines. Statistical analyzes were applied to evaluate the diagnostic value and the associations of Cry1 expression with clinical parameters.RESULTS: Cry1 expression was up regulated in the majority of the CRC cell lines and 168 primary CRC clinical specimens at the protein level. Clinical pathological analysis showed that Cry1 expression was significantly correlated with lymph node metastasis (p = 0.004) and the TNM stage (p = 0.003). High Cry1 expression was associated with poor overall survival in CRC patients (p = 0.010). Experimentally, we found that up-regulation of Cry1 promoted the proliferation and migration of HCT116 cells, while down-regulation of Cry1 inhibited the colony formation and migration of SW480 cells.CONCLUSIONS: These results suggest that Cry1 likely plays important roles in CRC development and progression andCry1 may be a prognostic biomarker and a promising therapeutic target for CRC.

Cry 1 Regulates the Clock Gene Network and Promotes Proliferation and Migration Via the Akt/P53/P21 Pathway in Human Osteosarcoma Cells

Cryptochrome 2 (CRY2) Suppresses Proliferation and Migration and Regulates Clock Gene Network in Osteosarcoma Cells

The circadian gene CRY2 is associated with breast cancer aggressiveness possibly via epigenomic modifications

Cryptochrome 1 Regulates Osteoblast Differentiation via the AKT Kinase and Extracellular Signal-Regulated Kinase Signaling Pathways.

Cryptochrome 1 Overexpression Correlates with Tumor Progression and Poor Prognosis in Patients with Colorectal Cancer

Cryptochrome 1 Promotes Osteogenic Differentiation of Human Osteoblastic Cells Via Wnt/β-Catenin Signaling.

Deregulated Expression of Cry1 and Cry2 in Human Gliomas

High level of αB-crystallin contributes to the progression of osteosarcoma.

CRY2 missense mutations suppress P53 and enhance cell growth

The Clock Gene PER1 Plays an Important Role in Regulating the Clock Gene Network in Human Oral Squamous Cell Carcinoma Cells

Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Cryptochrome 1 Promotes Low-Level Laser Irradiation-Induced Bone Marrow Mesenchymal Stem Cells Proliferation and Differentiation

The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repair

Activation of TNF‐α/NF‐κB Axis Enhances CRL4BDCAF11 E3 Ligase Activity and Regulates Cell Cycle Progression in Human Osteosarcoma Cells

RNF38 Inhibits Osteosarcoma Cell Proliferation by Binding to CRY1.

Silencing of cytoskeleton-associated protein 2 represses cell proliferation and induces cell cycle arrest and cell apoptosis in osteosarcoma cells.

CircRNA-CIRH1A Promotes the Development of Osteosarcoma by Regulating PI3K/AKT and JAK2/STAT3 Signaling Pathways

Circadian Gene Hclock Enhances Proliferation and Inhibits Apoptosis of Human Colorectal Carcinoma Cells in Vitro and in Vivo

Circadian clock components RORα and Bmal1 mediate the anti-proliferative effect of MLN4924 in osteosarcoma cells.

Circ_0010220-mediated Mir-503-5p/cdca4 Axis Contributes to Osteosarcoma Progression Tumorigenesis.

Cryptochrome 2 Acetylation Attenuates Its Antiproliferative Effect in Breast Cancer